VPN Plus+ ExclusiveCurrent Literature Review of Cannabinoids for Pain in Veterinary SpeciesMarch 8, 2024In this session: Stephen Niño Cital, RVT, SRA, RLAT, CVPP, VTS (LAM-Res. Anesthesia), discusses our current understanding of cannabinoids and their use for pain management in veterinary species. He also addresses the most current studies from design to results and how this applies to practice.
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more
Cannabinoids: It's all about the petNovember 6, 2023The use of cannabinoids in veterinary medicine is growing. What is less clear is the treatment across veterinary species, and the first necessary step into the use of cannabidiol (CBD) and cannabidiolic acid (CBDA) is to assess the pharmacokinetics in the species of intent.
Pet cannabinoids brand expands into EuropeFebruary 21, 2023Portland, Maine-based pet CBD+CBDA company, ElleVet Sciences, opens new headquarters in Haarlem, the Netherlands.
VPN Plus+ ExclusiveCannabinoids in the Clinic: Practical ApproachesJanuary 19, 2023In this session: The clinical data for companion animals with the use of cannabinoids, like CBD, has been growing. Stephen Niño Cital, RVT, SRA, RLAT, CVPP, VTS-LAM (Res. Anesthesia) discusses the current and relevant literature and dosing for safe and effective use of CBD in your practice.
VPN Plus+ ExclusiveWhat to look for in a quality CBD productNovember 3, 2022Imagine if the pharmaceuticals we prescribe for animals harbored unclear and undisclosed ingredients, in any quantity, with minimal evidence about their safety or effectiveness, and chemical makeup that varied with each shipment. This might sound intolerable, but it describes the status of not only cannabis, but botanical medicine in general.
